These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12552542)

  • 21. Familial hypertrophic cardiomyopathy associated with spontaneous complete heart block.
    Thongtang V; Panchavinin P; Chaithiraphan S
    J Med Assoc Thai; 1991 Jul; 74(7):301-5. PubMed ID: 1765747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
    Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy.
    Monakier D; Woo A; Puri T; Schwartz L; Ross J; Jamorski M; Yang H; Liu Z; Vannan M; Wigle ED; Rakowski H
    Am J Cardiol; 2004 Dec; 94(12):1515-22. PubMed ID: 15589007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD
    J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conservative management of complete heart block complicating percutaneous transluminal septal myocardial ablation for patients with obstructive hypertrophic cardiomyopathy.
    Cheng TO
    Am J Cardiol; 2004 Oct; 94(7):982. PubMed ID: 15464700
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Familial complete atrioventricular block in patients with hypertrophic cardiomyopathy].
    Albanesi Filho FM; Ginefra P; Castier MB; da Rocha PJ; de Albuquerque DC
    Arq Bras Cardiol; 1992 Sep; 59(3):209-13. PubMed ID: 1341172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of complete heart block following percutaneous transluminal septal myocardial ablation for patients with hypertrophic cardiomyopathy.
    Cheng TO
    Int J Cardiol; 2009 Jan; 131(3):420. PubMed ID: 18023896
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of biventricular pacing on left ventricular outflow tract pressure gradient in a patient with hypertrophic cardiomyopathy and normal interventricular conduction.
    Komsuoglu B; Vural A; Agacdiken A; Ural D
    J Cardiovasc Electrophysiol; 2006 Feb; 17(2):207-9. PubMed ID: 16533259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed occurrence of unheralded phase IV complete heart block after ethanol septal ablation for symmetric hypertrophic obstructive cardiomyopathy.
    Wykrzykowska JJ; Kwaku K; Wylie J; Manning WJ; Josephson ME; Zimetbaum P; Laham RJ
    Pacing Clin Electrophysiol; 2006 Jun; 29(6):674-8. PubMed ID: 16784435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic value of acute heart block after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy].
    Hou AJ; Duan N; Yang L; Li HJ; Li ZQ; Yuan L; Guan RM; Liu Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):149-51. PubMed ID: 19719994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications of low-dose, echo-guided alcohol septal ablation.
    Veselka J; Zemánek D; Tomasov P; Homolová S; Adlová R; Tesar D
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):546-50. PubMed ID: 20014165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can pacemakers cause life-threatening arrhythmias?
    Thompson C; Tsiperfal A; Al-Ahmad A
    Prog Cardiovasc Nurs; 2005; 20(4):184-5. PubMed ID: 16276144
    [No Abstract]   [Full Text] [Related]  

  • 35. Nuclear magnetic resonance for the assessment of the effects of alcohol septal ablation in hypertrophic cardiomyopathy.
    Kornacewicz-Jach Z; Wojtarowicz A; Goos H; Schulz-Menger J; Goracy J; Płońska E; Przybycień K
    Kardiol Pol; 2004 Nov; 61(11):461-7. PubMed ID: 15883594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Golden jubilee of hypertrophic cardiomyopathy: is alcohol septal ablation the gold standard?
    Parakh N; Bhargava B
    Cardiovasc Revasc Med; 2009; 10(3):172-8. PubMed ID: 19595399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Septal alcoholisation of hypertrophic obstructive cardiomyopathy in childhood].
    Abbey S; Guérin P; Gournay V; Lefevre M; Crochet D
    Arch Mal Coeur Vaiss; 2005 May; 98(5):574-8. PubMed ID: 15966612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pacing for heart block after septal reduction therapy.
    Okreglicki AM
    Am J Cardiol; 2004 Nov; 94(9):1224. PubMed ID: 15518634
    [No Abstract]   [Full Text] [Related]  

  • 39. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: is it safe?
    Veselka J
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):520-1; author reply 522. PubMed ID: 19496117
    [No Abstract]   [Full Text] [Related]  

  • 40. Occurrence of de novo sustained monomorphic ventricular tachycardia induced after percutaneous transluminal alcohol septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Hori Y; Ueda M; Nakayama T; Saegusa N; Uehara M; Lee K; Sekine T; Daimon M; Kobayashi Y; Funabashi N; Komuro I
    Int J Cardiol; 2007 Jul; 119(3):403-7. PubMed ID: 17069908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.